DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Lamotrigine

Lamotrigine

  • Eslicarbazepine Acetate: a New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures

    Eslicarbazepine Acetate: a New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures

  • Chapter 25 Mechanisms of Action of Antiepileptic Drugs

    Chapter 25 Mechanisms of Action of Antiepileptic Drugs

  • Clinical Review, Adverse Events

    Clinical Review, Adverse Events

  • APTIOM (Eslicarbazepine Acetate) Is (S)-10-Acetoxy-10,11-Dihydro-5H­ Dibenz[B,F]Azepine-5-Carboxamide

    APTIOM (Eslicarbazepine Acetate) Is (S)-10-Acetoxy-10,11-Dihydro-5H­ Dibenz[B,F]Azepine-5-Carboxamide

  • Journal of Central Nervous System Disease a Review Of

    Journal of Central Nervous System Disease a Review Of

  • Beyond Amitriptyline

    Beyond Amitriptyline

  • Serotonin Syndrome in the Setting of Lamotrigine, Aripiprazole, and Cocaine Use

    Serotonin Syndrome in the Setting of Lamotrigine, Aripiprazole, and Cocaine Use

  • Medications and Electroconvulsive Therapy

    Medications and Electroconvulsive Therapy

  • Voltage-Gated Sodium Channels and Blockers: an Overview and Where Will They Go?*

    Voltage-Gated Sodium Channels and Blockers: an Overview and Where Will They Go?*

  • EFNS Guideline Restless Legs Syndrome

    EFNS Guideline Restless Legs Syndrome

  • Lamictal 25 Mg, 50 Mg, 100 Mg and 200 Mg Tablets Lamotrigine

    Lamictal 25 Mg, 50 Mg, 100 Mg and 200 Mg Tablets Lamotrigine

  • Dopminergic Treatment of Treatment Refractory Mood Disorders

    Dopminergic Treatment of Treatment Refractory Mood Disorders

  • A New Rapid Titration Protocol for Lamotrigine That Reduces

    A New Rapid Titration Protocol for Lamotrigine That Reduces

  • APTIOM (Eslicarbazepine Acetate) Tablets, for Oral Use • Withdrawal of APTIOM: Withdraw APTIOM Gradually to Minimize the Initial U.S

    APTIOM (Eslicarbazepine Acetate) Tablets, for Oral Use • Withdrawal of APTIOM: Withdraw APTIOM Gradually to Minimize the Initial U.S

  • Study Protocol SEP093-701

    Study Protocol SEP093-701

  • Topiramate Pharmacotherapy for Alcohol Use Disorder and Other

    Topiramate Pharmacotherapy for Alcohol Use Disorder and Other

  • Propranolol Shows Early Promise for PTSD

    Propranolol Shows Early Promise for PTSD

  • Chronic Imipramine but Not Bupropion Increases Arachidonic Acid

    Chronic Imipramine but Not Bupropion Increases Arachidonic Acid

Top View
  • The Safety of Medications Used to Treat
  • Lamotrigine Augmentation of Serotonin Reuptake Inhibitors In
  • Magnesium in Ketamine Administration in Treatment-Resistant Depression
  • Therapeutic Class Overview Restless Legs Syndrome
  • Drug Eruptions: 6 Dangerous Rashes
  • Horizant (Gabapentin Enacarbil Extended-Release Tablets)
  • Recommended Dose of Gabapentin
  • Effectiveness of Amitriptyline and Lamotrigine in Neuropathic Pain After Traumatic Spinal Cord Injuries
  • Effectiveness of Amitriptyline and Lamotrigine in Traumatic Spinal Cord Injury-Induced Neuropathic Pain: a Randomized Longitudinal Comparative Study
  • FDA Safety Warning on the Cardiac Effects of Lamotrigine: an Advisory from the Ad Hoc ILAE/AES Task Force
  • Neuropathic Pain
  • LAMICTAL Lamotrigine 2 Mg, 5 Mg, 25 Mg, 50 Mg, 100 Mg Dispersible/Chewable Tablets
  • Commonly Prescribed Psychotropic Medications
  • FDA Safety Warning on the Cardiac Effects of Lamotrigine: an Advisory from the Ad Hoc ILAE/AES Task Force
  • FDA Drug Safety Communication: Studies Show Increased Risk Of
  • Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
  • Conversion to Eslicarbazepine Acetate Monotherapy a Pooled Analysis of 2 Phase III Studies
  • Pharmacological Interventions for the Prevention Of


© 2024 Docslib.org    Feedback